Related Experiment Video
Updated: Sep 21, 2025

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
Aryl Hydrocarbon Receptor Directly Regulates VTCN1 Gene Expression in MCF-7 Cells
Naoya Yamashita1, Kyoko Yoshida1, Noriko Sanada1
1Faculty of Pharmaceutical Sciences, Doshisha Women's College of Liberal Arts.
Abstract:
The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that mediates the toxicity of dioxins and polycyclic aromatic hydrocarbons. Recent studies have suggested that AhR is involved in cancer immunity. In the present study, we examined whether AhR regulates the expression of immune checkpoint genes in breast cancer cells. We discovered that the mRNA expression of V-set domain containing T cell activation inhibitor 1 (VTCN1) that negatively regulates T cell immunity was upregulated by AhR agonists in breast cancer cell lines, MCF-7 and T47D. Furthermore, AhR knockout or knockdown experiments clearly demonstrated that upregulation of VTCN1 gene expression by 3-methylcholanthrene was AhR dependent. Luciferase reporter and chromatin immunoprecipitation assays revealed that this upregulation of VTCN1 gene expression was induced by the recruitment of AhR to the AhR responsive element in the VTCN1 gene promoter in MCF-7 cells. Taken together, AhR directly regulates VTCN1 gene expression in MCF-7 cells.
Insights
The aryl hydrocarbon receptor (AhR) directly upregulates V-set domain containing T cell activation inhibitor 1 (VTCN1) in breast cancer cells. This finding reveals a novel mechanism influencing cancer immunity via AhR regulation of immune checkpoints.
Area of Science:
- Immunology
- Molecular Biology
- Cancer Research
Background:
- The aryl hydrocarbon receptor (AhR) is a transcription factor known for mediating dioxin toxicity.
- Emerging evidence suggests AhR's role in cancer immunity.
- Immune checkpoint genes are critical regulators of anti-tumor immune responses.
Purpose of the Study:
- To investigate if the aryl hydrocarbon receptor (AhR) regulates immune checkpoint gene expression in breast cancer.
- To determine the specific immune checkpoint gene(s) affected by AhR activation.
- To elucidate the mechanism of AhR-mediated regulation of these genes.
Main Methods:
- Treatment of breast cancer cell lines (MCF-7, T47D) with AhR agonists.
- AhR knockout and knockdown experiments to assess gene regulation.
- Luciferase reporter assays to confirm promoter activity.
- Chromatin immunoprecipitation assays to identify AhR binding sites.
Main Results:
- AhR agonists upregulated V-set domain containing T cell activation inhibitor 1 (VTCN1) mRNA expression in MCF-7 and T47D cells.
- Upregulation of VTCN1 by 3-methylcholanthrene was dependent on AhR presence.
- AhR was recruited to the AhR responsive element in the VTCN1 promoter, confirming direct regulation.
Conclusions:
- The aryl hydrocarbon receptor (AhR) directly upregulates VTCN1 gene expression in breast cancer cells.
- AhR-mediated regulation of VTCN1 represents a novel mechanism in cancer immunity.
- Targeting AhR could potentially modulate immune checkpoint expression in breast cancer therapy.
More Related Videos
10:49Efficient Transcriptionally Controlled Plasmid Expression System for Investigation of the Stability of mRNA Transcripts in Primary Alveolar Epithelial Cells
Published on: March 6, 2020
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Related Concept Videos
Cell Specific Gene Expression
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Regulation of Angiogenesis and Blood Supply
Canonical Wnt Signaling Pathway
GPCRs Regulate Adenylyl Cylase Activity
Co-activators and Co-repressors